Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study

Clinical Presentation and Long‐Term Survival Outcomes of Patients With Monoclonal Gammopathy of Renal Significance (MGRS): A Multicenter Retrospective Study

ABSTRACT Introduction MGRS are new rare clinical entities, whose recognition and optimal management is evolving. Methods To implement real‐life data, we retrospectively analysed a multicentre cohort of 60 patients with renal biopsy‐proven MGRS receiving mainly novel treatments (between 2006 and 2021...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. Mancuso, R. Mina, S. Rocchi, E. Antonioli, M. T. Petrucci, F. Fazio, A. Gozzetti, M. Salvini, C. S. Cartia, G. Bertuglia, F. Patriarca, A. B. Dalla Palma, S. Barbato, G. De Cicco, F. Bigi, E. Favero, P. Tacchetti, L. Pantani, I. Rizzello, M. Puppi, M. Talarico, V. Solli, A. Kanapari, M. Cavo, E. Zamagni
Format:	Article
Language:	English
Published:	Wiley 2024-11-01
Series:	Cancer Medicine
Online Access:	https://doi.org/10.1002/cam4.70266
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnostic and Therapeutic Aspects of Monoclonal Gammopathies of Renal Significance (MGRS): An Update
by: Giuseppe Stefano Netti, et al.
Published: (2024-12-01)

WCN25-4500 INCIDENCE AND RISK FACTORS FOR MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE (MGRS) IN PATIENTS WITH MONOCLONAL GAMMOPATHY AND RENAL DISEASE
by: Henrique Borges, et al.
Published: (2025-02-01)

WCN25-4506 CLINICAL AND PATHOLOGIC FEATURES OF MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE (MGRS) LESIONS
by: Filipa Fonte Rodrigues, et al.
Published: (2025-02-01)

Progression of IgM Monoclonal Gammopathy of Renal Significance (MGRS) to Symptomatic Waldenström Macroglobulinemia: A Case Report
by: Kenichi Ito, et al.
Published: (2025-07-01)

WCN24-2690 Rapidly Progressive Glomerulonephritis (RPGN) Secondary to Immunoglobulin M Associated Renal Significance Monoclonal Gammopathy (MGRS): A Case Report
by: Daniel Hernando Rodriguez Peralta, et al.
Published: (2024-04-01)

Unique molecular assay (UMA): a next-generation sequencing targeted panel for efficient and comprehensive genomic profiling and risk stratification of multiple myeloma
by: Andrea Poletti, et al.
Published: (2025-05-01)

WCN25-3575 A rare case of MGRS – PGNMID with light chain restriction only
by: Anitha Ramavajula, et al.
Published: (2025-02-01)

Generalized Acquired Cutis Laxa Associated with Monoclonal Gammopathy of Dermatological Significance
by: Sophia Z. Shalhout, et al.
Published: (2020-01-01)

Clinical and Pathological Characteristics of Non-AL Amyloidosis MGRS: A Single-Center Experience Over 10 Years
by: Chunpeng Nie, et al.
Published: (2025-02-01)

Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology
by: A. V. Smirnov, et al.
Published: (2020-07-01)

Hematologists/Physicians Need to Be Aware of Pseudohypercalcemia in Monoclonal Gammopathy: Lessons from a Case Report
by: Svenja F. B. J. Mennens, et al.
Published: (2024-01-01)

Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma
by: Elizabeth K. O’Donnell, et al.
Published: (2025-04-01)

The experience of free light chains of immunoglobulin elimination in patients with monoclonal gammopathies
by: E. G. Gromova, et al.
Published: (2019-07-01)

Helicobacter pylori Infection and Light Chain Gammopathy
by: José A. Girón, et al.
Published: (2013-01-01)

Unusual Cases of Monoclonal Gammopathy of Renal Significance
by: Anjellica Chen, et al.
Published: (2024-01-01)

Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency
by: Remy S. Petersen, MD, et al.
Published: (2024-11-01)

PARAPROTEINEMIC POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: СLINICAL CASE DESCRIPTION AND LITERATURE REVIEW
by: A. A. Yakovlev, et al.
Published: (2017-09-01)

Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance
by: Melissa A. Lyle, et al.
Published: (2022-01-01)

Monoclonal gammopathy of renal significance: From bench to bedside
by: Megha Saigal, et al.
Published: (2025-01-01)

Monoclonal gammopathy in WHIM syndrome can mask hypogammaglobulinemia
by: Julia Lew, MD, et al.
Published: (2025-08-01)

Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China
by: Anping Xu, et al.
Published: (2024-12-01)

Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance
by: Holly Lee, et al.
Published: (2019-01-01)

Plasma cell dyscrasia: monoclonal gammopathies, AL-amyloidosis, multiple myeloma Clinical case study
by: V. V. Cherepanova, et al.
Published: (2023-03-01)

A complicated case of cutaneous necrotizing vasculitis associated with monoclonal gammopathy. Case report
by: Irina G. Rekhtina, et al.
Published: (2025-01-01)

Monoclonal Gammopathy of Renal Significance: Consensus of Hematologists and Nephrologists of Russia on the Establishment of Nosology, Diagnostic Approach and Rationale for Clone Specific Treatment
by: A. V. Smirnov, et al.
Published: (2020-03-01)

Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population‐based screening study
by: Sæmundur Rögnvaldsson, et al.
Published: (2024-11-01)

Waldenstrom’s Macroglobulinemia and Peripheral Neuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes with a Bleeding Diathesis and Rash
by: S. Haider, et al.
Published: (2013-01-01)

The role of bone marrow microenvironment in the progression of multiple myeloma from monoclonal gammopathy of undetermined significance
by: A. S. Khudovekova, et al.
Published: (2021-09-01)

Screening for monoclonal gammopathies of undetermined significance: A prospective study
by: Aissam El Maataoui, et al.
Published: (2025-03-01)

Transient Monoclonal Gammopathy Induced by Disseminated Staphylococcus aureus Infection
by: Dimitrios Stoimenis, et al.
Published: (2012-01-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

Gamma gap and albumin-globulin ratio show poor sensitivity for monoclonal gammopathy screening in South Africa
by: Njabulo Khumalo, et al.
Published: (2025-03-01)

Corrigendum to “First-line therapy with daratumumab, lenalidomide and dexamethasone for patient with POEMS syndrome: A case report” [Leukemia Research Reports (2024) Volume 22, 100491]
by: E. Amabile, et al.
Published: (2025-01-01)

Clinical features of monoclonal gammopathy of renal significance related renal lesions
by: Xiao-jing Wu, et al.
Published: (2022-08-01)

Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy
by: Alba Rodríguez-García, et al.
Published: (2025-02-01)

Management of Acute Episodes of Clarkson Disease (Monoclonal Gammopathy-Associated Systemic Capillary Leak Syndrome) With Intravenous Immunoglobulins
by: Mark S. Pecker, et al.
Published: (2022-08-01)

Monoclonal Gammopathies of Clinical Significance—Scleromyxedema: A Case Report and Literature Review
by: Shanshan Liang, et al.
Published: (2025-08-01)

First-line therapy with daratumumab, lenalidomide and dexamethasone for patient with POEMS syndrome: A case report
by: E. Amabile, et al.
Published: (2024-01-01)

Clinical Presentation, Renal Histopathological Findings, and Outcome in Patients with Monoclonal Gammopathy and Kidney Disease
by: Gaetano Alfano, et al.
Published: (2021-01-01)

A case of renal damage induced by cryoglobulinemia associated with Monoclonal Gammopathy of Renal Significance
by: Yan Zhang, et al.
Published: (2025-07-01)